Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of 1-Methylimidazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.71 |
| ▸ | QPCT | Q16769 | 1/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.71 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.71 |
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TBXAS1 | P24557 | 7/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.32 |
| ▸ | FABP4 | P15090 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1-Methylimidazole SCHEMBL27681653 | 1.00 | NFKB1 (0.71) | NFKB1QPCTHSD17B10QPCTLHTT | |
| 1-Methylimidazole SCHEMBL693786 | 1.00 | NFKB1 (0.71) | NFKB1QPCTHSD17B10QPCTLHTT | |
| 1-Methylimidazole SCHEMBL27724089 | 0.98 | NFKB1 (0.68) | NFKB1QPCTHSD17B10QPCTLHTT | |
| 1-Methylimidazole SCHEMBL27993647 | 0.98 | NFKB1 (0.68) | NFKB1QPCTHSD17B10QPCTLHTT | |
| 1-Methylimidazole SCHEMBL28175971 | 0.96 | NFKB1 (0.65) | NFKB1QPCTHSD17B10QPCTLHTT | |
| 1-Methylimidazole SCHEMBL28194536 | 0.93 | QPCT (0.68) | NFKB1QPCTHSD17B10QPCTLHTT | |
| 1-Methylimidazole SCHEMBL459534 | 0.93 | QPCT (0.68) | NFKB1QPCTHSD17B10QPCTLHTT | |
| 1-Methylimidazole SCHEMBL29777918 | 0.92 | NFKB1 (0.60) | NFKB1QPCTHSD17B10QPCTLHTT | |
| 1-Methylimidazole SCHEMBL28122307 | 0.92 | NFKB1 (0.60) | NFKB1QPCTHSD17B10QPCTLHTT | |
| 1-Methylimidazole SCHEMBL29110568 | 0.91 | NFKB1 (0.65) | NFKB1QPCTHSD17B10QPCTLHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024042159-A1 | CONDUCTIVE PRESSURE SENSITIVE ADHESIVE | HENKEL AG & CO. KGAA (DE) | 2024-02-29 | — | — | WO | claimed |
| CN-111117594-A | Electrochromic material based on dynamic metal-ligand complexation and electrochromic device | 吉林大学 | 2020-05-08 | — | — | CN | claimed |
| WO-2008022983-A2 | CONDUCTIVE POLYMER GELS | BASF SE (DE) | 2008-02-28 | — | — | WO | claimed |
| EP-1663921-B1 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AG (DE) | 2007-05-02 | — | — | EP | claimed |
| US-20070055084-A1 | Method for producing haloalkanes from alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-08 | — | — | US | claimed |
| EP-1663921-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-07 | — | — | EP | claimed |
| WO-2005026089-A2 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-24 | — | — | WO | claimed |
| CN-116867885-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2023-10-10 | — | — | CN | disclosed |
| CN-111836849-B | Process for producing fibers, films and moldings of polybenzazole polymer (P) | 巴斯夫欧洲公司 | 2023-04-07 | — | — | CN | disclosed |
| EP-3512905-B1 | METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) | BASF SE (DE) | 2022-08-24 | — | — | EP | disclosed |
| CN-109790292-B | Process for preparing polybenzazole polymer (P) | 巴斯夫欧洲公司 | 2022-05-31 | — | — | CN | disclosed |
| CN-109504015-B | Electrochromic polymer material based on combination strategy and preparation of electrochromic device | 常州铱视光电科技有限公司 | 2021-05-11 | — | — | CN | disclosed |
| EP-3762447-A1 | METHOD FOR PRODUCING FIBRES, FILMS AND MOULDED BODIES OF A POLYBENZAZOLE POLYMER (P) | BASF SE (DE) | 2021-01-13 | — | — | EP | disclosed |
| WO-2019170529-A1 | METHOD FOR PRODUCING FIBRES, FILMS AND MOULDED BODIES OF A POLYBENZAZOLE POLYMER (P) | BASF SE (DE) | 2019-09-12 | — | — | WO | disclosed |
| EP-3512905-A1 | METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) | BASF SE (DE) | 2019-07-24 | — | — | EP | disclosed |
| EP-3322527-A1 | METHOD FOR PREPARING BIOSOURCED IONIC LIQUIDS FOR CATALYSIS | Université de Bourgogne (FR) | 2018-05-23 | — | — | EP | disclosed |
| WO-2018069237-A1 | BETAINE (B) AND METHOD FOR THE PRODUCTION THEREOF | BASF SE (DE) | 2018-04-19 | — | — | WO | disclosed |
| WO-2018050489-A1 | METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) | BASF SE (DE) | 2018-03-22 | — | — | WO | disclosed |
| EP-1663921-B1 | METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS | BASF AG (DE) | 2007-05-02 | — | — | EP | disclosed |
| US-20070055084-A1 | Method for producing haloalkanes from alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070055084-A1 | Method for producing haloalkanes from alcohols | ADH1C, HDHD5, ADH5 | NFKB1 2976/4885QPCT 510/4885HSD17B10 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.